{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:36:16Z","timestamp":1792888576594,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004255","name":"Rajiv Gandhi University of Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.118013","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:40:49Z","timestamp":1777732849000},"page":"118013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Pharmacological and neurobehavioral evaluation of the bifunctional opioid peptide Gluten exorphin B5"],"prefix":"10.1016","volume":"250","author":[{"given":"Vishwadeep","family":"Asokan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Aranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5\u20136","key":"10.1016\/j.bcp.2026.118013_b0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000508773","article-title":"Anhedonia in depressive disorder: a narrative review","volume":"53","author":"De Fruyt","year":"2020","journal-title":"Psychopathology"},{"issue":"4","key":"10.1016\/j.bcp.2026.118013_b0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00787-019-01364-y","article-title":"Understanding anhedonia: a qualitative study exploring loss of interest and pleasure in adolescent depression","volume":"29","author":"Watson","year":"2020","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2026.118013_b0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.31887\/DCNS.2008.10.3\/shkennedy","article-title":"Core symptoms of major depressive disorder: relevance to diagnosis and treatment","volume":"10","author":"Kennedy","year":"2008","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bcp.2026.118013_b0020","doi-asserted-by":"crossref","unstructured":"Major Depression: One Brain, One Disease, One Set of Intertwined Processes [Internet]. [cited 2026 Feb 7]. Available from: https:\/\/www.mdpi.com\/2073-4409\/10\/6\/1283.","DOI":"10.3390\/cells10061283"},{"key":"10.1016\/j.bcp.2026.118013_b0025","unstructured":"Edition F. Diagnostic and statistical manual of mental disorders. American psychiatric association, Washington, DC. 1980;205\u201324."},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-020-0200-2","article-title":"Comorbid depression in medical diseases","volume":"6","author":"Gold","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.bcp.2026.118013_b0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0004867417700274","article-title":"Depressive symptom trajectories in late adolescence and early adulthood: a systematic review","volume":"51","author":"Schubert","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/19012276.2016.1267913","article-title":"Depression: diagnosis and suffering as process","volume":"69","author":"Petersen","year":"2017","journal-title":"Nord. Psychol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/2156869310393986","article-title":"Creating an age of depression: the social construction and consequences of the major depression diagnosis","volume":"1","author":"Horwitz","year":"2011","journal-title":"Soc. Ment. Health."},{"key":"10.1016\/j.bcp.2026.118013_b0050","first-page":"1","article-title":"The influence of doomscrolling on mental health: a scoping review","volume":"30","author":"Sharpe","year":"2026","journal-title":"Ment. Health Digit. Technol."},{"key":"10.1016\/j.bcp.2026.118013_b0055","unstructured":"The Relationships Between Doomscrolling and Anxiety, Depression, and Coping - ProQuest [Internet]. [cited 2026 Feb 7]. Available from: https:\/\/www.proquest.com\/openview\/bcca62c0d1ff8407d45cdb744300eafa\/1?pq-origsite=gscholar&cbl=18750&diss=y."},{"key":"10.1016\/j.bcp.2026.118013_b0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.31690\/ijnr.2022.v08i04.002","article-title":"Doomscrolling \u2013 threat to mental health and well-being: a review","author":"Rodrigues","year":"2022","journal-title":"Int. J. Nurs. Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118013_b0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.52053\/jpap.v6i4.464","article-title":"Learned helplessness and existential anxiety among emerging adults","volume":"6","author":"Zainab","year":"2025","journal-title":"J. Professional Appl. Psychol."},{"issue":"281","key":"10.1016\/j.bcp.2026.118013_b0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2020.12.035","article-title":"Global trends in the prevalence and incidence of depression:a systematic review and meta-analysis","volume":"15","author":"Moreno-Agostino","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"295","key":"10.1016\/j.bcp.2026.118013_b0075","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jad.2021.09.038","article-title":"Estimating the global treatment rates for depression: a systematic review and meta-analysis","volume":"1","author":"Mekonen","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.bcp.2026.118013_b0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bjc.12333","article-title":"Global prevalence of depression and elevated depressive symptoms among adolescents: a systematic review and meta-analysis","volume":"61","author":"Shorey","year":"2022","journal-title":"Br. J. Clin. Psychol."},{"issue":"178","key":"10.1016\/j.bcp.2026.118013_b0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpsychires.2024.07.054","article-title":"Change in the global burden of depression from 1990-2019 and its prediction for 2030","volume":"1","author":"Zhang","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/amhs.amhs_7_18","article-title":"Neuropharmacological classification of antidepressant agents based on their mechanisms of action","volume":"6","author":"Fasipe","year":"2018","journal-title":"Arch. Med. Health Sci."},{"issue":"9","key":"10.1016\/j.bcp.2026.118013_b0095","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14737175.6.9.1249","article-title":"Bupropion: pharmacology and therapeutic applications","volume":"6","author":"Foley","year":"2006","journal-title":"Expert Rev. Neurother."},{"issue":"3","key":"10.1016\/j.bcp.2026.118013_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"issue":"4","key":"10.1016\/j.bcp.2026.118013_b0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00003495-197816040-00001","article-title":"Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness","volume":"16","author":"Brogden","year":"1978","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.bcp.2026.118013_b0110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr."},{"issue":"4","key":"10.1016\/j.bcp.2026.118013_b0115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2165\/00003495-199753040-00006","article-title":"Nefazodone","volume":"53","author":"Davis","year":"1997","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bcp.2026.118013_b0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/17460441.2016.1160051","article-title":"The preclinical and clinical effects of vilazodone for the treatment of major depressive disorder","volume":"11","author":"Sahli","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"issue":"6","key":"10.1016\/j.bcp.2026.118013_b0125","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40262-017-0612-7","article-title":"Vortioxetine: clinical pharmacokinetics and drug interactions","volume":"57","author":"Chen","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.bcp.2026.118013_b0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40263-018-0519-3","article-title":"Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review","volume":"32","author":"Molero","year":"2018","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.encep.2007.12.001","article-title":"Antidepressants and their onset of action: a major clinical, methodological and pronostical issue","volume":"34","author":"Gourion","year":"2008","journal-title":"Encephale"},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0140","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.mp.4001015","article-title":"Delayed pharmacological effects of antidepressants","volume":"7","author":"Frazer","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"219","key":"10.1016\/j.bcp.2026.118013_b0145","article-title":"MAO inhibitors for treatment-resistant depression: bringing an updated perspective on pioneering drugs","volume":"1","author":"Junkes","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118013_b0150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118013_b0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/YIC.0000000000000574","article-title":"Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study","volume":"40","author":"Chen","year":"2025","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bcp.2026.118013_b0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.36740\/WLek\/197143","article-title":"From efficacy to adversity: understanding the side effects of antidepressants - systematic review","volume":"1","author":"Hrabar","year":"2025","journal-title":"Wiadomo\u015bci Lekarskie."},{"issue":"2","key":"10.1016\/j.bcp.2026.118013_b0165","first-page":"132","article-title":"Opioid peptides","volume":"21","author":"Froehlich","year":"1997","journal-title":"Alcohol Health Res. World"},{"key":"10.1016\/j.bcp.2026.118013_b0170","unstructured":"A. Koneru, S. Satyanarayana, S. Rizwan. Endogenous Opioids: Their Physiological Role and Receptors. 2009;."},{"issue":"6","key":"10.1016\/j.bcp.2026.118013_b0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br. J. Anaesth."},{"issue":"14","key":"10.1016\/j.bcp.2026.118013_b0180","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/bph.13812","article-title":"Opioid system and human emotions","volume":"175","author":"Nummenmaa","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0185","first-page":"5","article-title":"Opioid system modulates the immune function: a review","volume":"1","author":"Liang","year":"2016","journal-title":"Transl. Perioper Pain Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0190","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12629","article-title":"Role of food-derived opioid peptides in the central nervous and gastrointestinal systems","volume":"43","author":"Liu","year":"2019","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.bcp.2026.118013_b0195","unstructured":"A. Mansour, H. Khachaturian, M.E. Lewis, H. Akil, S.J. Watson. Anatomyof CN$opMdreceptors."},{"issue":"2","key":"10.1016\/j.bcp.2026.118013_b0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000368279","article-title":"The nucleus accumbens: a comprehensive review","volume":"93","author":"Salgado","year":"2015","journal-title":"Stereotact. Funct. Neurosurg."},{"issue":"14","key":"10.1016\/j.bcp.2026.118013_b0205","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2174\/138161209788168100","article-title":"Opiates as Antidepressants","volume":"15","author":"Berrocoso","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"9","key":"10.1016\/j.bcp.2026.118013_b0210","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/mp.2013.115","article-title":"Antidepressant-like and anxiolytic-like effects following activation of the \u03bc-\u03b4 opioid receptor heteromer in the nucleus accumbens","volume":"19","author":"Kabli","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bcp.2026.118013_b0215","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5055\/jom.0954","article-title":"An overview of opioid peptides: their sources and molecular sequences","volume":"21","author":"Asokan","year":"2025","journal-title":"J. Opioid Manage."},{"key":"10.1016\/j.bcp.2026.118013_b0220","doi-asserted-by":"crossref","unstructured":"M.R. Ul Haq. Rubiscolins, Soymorphins, and Oryzatensin. In: Ul Haq MR, editor. Opioid Food Peptides: Significant Exorphins from Food Sources [Internet]. Singapore: Springer; 2020 [cited 2026 Feb 8]. p. 89\u2013104. Available from: https:\/\/doi.org\/10.1007\/978-981-15-6102-3_7.","DOI":"10.1007\/978-981-15-6102-3_7"},{"issue":"2","key":"10.1016\/j.bcp.2026.118013_b0225","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1389557517666170426160703","article-title":"Rubiscolins - highly potent peptides derived from plant proteins","volume":"18","author":"Perlikowska","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10989-019-09813-7","article-title":"Opioid peptides: an overview of functional significance","volume":"26","author":"Kaur","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-5793(92)80414-C","article-title":"Opioid peptides derived from wheat gluten: Their isolation and characterization","volume":"296","author":"Fukudome","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2026.118013_b0240","doi-asserted-by":"crossref","unstructured":"M.R. Ul Haq. Gluten Exorphins. In: Ul Haq MR, editor. Opioid Food Peptides: Significant Exorphins from Food Sources [Internet]. Singapore: Springer; 2020 [cited 2026 Feb 8]. p. 71\u201388. Available from: https:\/\/doi.org\/10.1007\/978-981-15-6102-3_6.","DOI":"10.1007\/978-981-15-6102-3_6"},{"issue":"72","key":"10.1016\/j.bcp.2026.118013_b0245","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.foodres.2015.04.002","article-title":"Release of wheat gluten exorphins A5 and C5 during in vitro gastrointestinal digestion of bread and pasta and their absorption through an in vitro model of intestinal epithelium","volume":"1","author":"Stuknyt\u0117","year":"2015","journal-title":"Food Res. Int."},{"issue":"22","key":"10.1016\/j.bcp.2026.118013_b0250","doi-asserted-by":"crossref","first-page":"8825","DOI":"10.3390\/ijms21228825","article-title":"Food-derived opioid peptides in human health: a review","volume":"21","author":"Tyagi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"242","key":"10.1016\/j.bcp.2026.118013_b0255","article-title":"Antidepressants and the endogenous opioid system","volume":"1","author":"Fricker","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118013_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.70014","article-title":"Gluten Exorphin B5: synthesis and characterization of a food-derived opioid peptide","volume":"117","author":"Asokan","year":"2025","journal-title":"Pept. Sci."},{"issue":"40","key":"10.1016\/j.bcp.2026.118013_b0265","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.3748\/wjg.v17.i40.4523","article-title":"YFa and analogs: Investigation of opioid receptors in smooth muscle contraction","volume":"17","author":"Kumar","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118013_b0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1043-6618(05)80124-0","article-title":"Guinea-pig ileum (GPI) and mouse vas deferens (MVD) preparations in the discovery, discrimination and parallel bioassay of opioid peptides","volume":"26","author":"Falconieri Erspamer","year":"1992","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2003.11.007","article-title":"The influence of cooperativity on the determination of dissociation constants: examination of the Cheng\u2013Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations","volume":"50","author":"Cheng","year":"2004","journal-title":"Pharmacol. Res."},{"issue":"16","key":"10.1016\/j.bcp.2026.118013_b0280","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0024-3205(82)90195-3","article-title":"Comparison of in vitro potencies in pharmacological and binding assays after inhibition of peptides reveals that dynorphin (1\u20139) is a potent \u03ba-agonist","volume":"31","author":"McKnight","year":"1982","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.118013_b0285","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0196-9781(86)90091-4","article-title":"Opioid receptor binding profile of selected dermorphin-like peptides","volume":"7","author":"Rossi","year":"1986","journal-title":"Peptides"},{"issue":"9","key":"10.1016\/j.bcp.2026.118013_b0290","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/sj.npp.1300959","article-title":"Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice","volume":"31","author":"Kuzmin","year":"2006","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.bcp.2026.118013_b0295","unstructured":"M. Ramdas Bhat, M.P. Jeshma, J. Fathima Shaheemah, M. Musthafa, A.R. Shabaraya. Evaluation of anti-anxiety activity of ethanolic extract of Jasminum sambac leaves in experimental animals."},{"issue":"3","key":"10.1016\/j.bcp.2026.118013_b0300","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.pbb.2006.09.019","article-title":"The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety","volume":"85","author":"Zarrindast","year":"2006","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41398-024-02830-1","article-title":"\u00b5-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice","volume":"14","author":"Nisbett","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.bcp.2026.118013_b0310","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/npp.2017.60","article-title":"The behavioral effects of the antidepressant tianeptine require the Mu-opioid receptor","volume":"42","author":"Samuels","year":"2017","journal-title":"Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2026.118013_b0315","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-5793(92)80414-C","article-title":"Opioid peptides derived from wheat gluten: their isolation and characterization","volume":"296","author":"Fukudome","year":"1992","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.bcp.2026.118013_b0320","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1021\/jm301456c","article-title":"Biological active analogues of the opioid peptide biphalin: mixed \u03b1\/\u03b23-peptides","volume":"56","author":"Mollica","year":"2013","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118013_b0325","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1254\/jjp.84.259","article-title":"Behavioral and pharmacological studies on gluten Exorphin A5, a newly isolated bioactive food protein fragment, in mice","volume":"84","author":"Takahashi","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"issue":"119","key":"10.1016\/j.bcp.2026.118013_b0330","article-title":"A plant-derived \u03b4 opioid receptor agonist rubiscolin-6 ameliorates sickness behavior in mice with cancer cachexia","volume":"1","author":"Iizasa","year":"2024","journal-title":"J. Funct. Foods"},{"issue":"9","key":"10.1016\/j.bcp.2026.118013_b0335","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0924-2244(01)00003-6","article-title":"Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides","volume":"11","author":"Pihlanto-Lepp\u00e4l\u00e4","year":"2000","journal-title":"Trends Food Sci. Technol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118013_b0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1389557517666170426160703","article-title":"Rubiscolins - highly potent peptides derived from plant proteins","volume":"18","author":"Perlikowska","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2026.118013_b0345","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/0929867323666160219115226","article-title":"Food proteins as source of opioid peptides-a review","volume":"23","author":"Garg","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118013_b0350","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.26599\/FSHW.2022.9250097","article-title":"Food-derived protein hydrolysates and peptides: anxiolytic and antidepressant activities, characteristics, and mechanisms","volume":"13","author":"Li","year":"2024","journal-title":"Food Sci. Human Wellness"},{"key":"10.1016\/j.bcp.2026.118013_b0355","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.peptides.2015.07.013","article-title":"Bioactive peptides derived from natural proteins with respect to diversity of their receptors and physiological effects","volume":"72","author":"Yoshikawa","year":"2015","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.bcp.2026.118013_b0360","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/138945012799201612","article-title":"Current research on opioid receptor function","volume":"13","author":"Feng","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bcp.2026.118013_b0365","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/AJP.0b013e3181c49d2e","article-title":"Molecular insights into \u03bc opioid pharmacology: from the clinic to the bench","volume":"26","author":"Pasternak","year":"2010","journal-title":"Clin. J. Pain"},{"issue":"6","key":"10.1016\/j.bcp.2026.118013_b0370","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40263-022-00924-2","article-title":"Current and future therapeutic options in pain management: multi-mechanistic opioids involving both MOR and NOP receptor activation","volume":"36","author":"Coluzzi","year":"2022","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.bcp.2026.118013_b0375","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0963689718811060","article-title":"Historical review: opiate addiction and opioid receptors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transplant."},{"issue":"8","key":"10.1016\/j.bcp.2026.118013_b0380","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/cancers14081992","article-title":"Treatment of neuropathic pain directly due to cancer: an update","volume":"14","author":"Shkodra","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bcp.2026.118013_b0385","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuron.2019.03.003","article-title":"A motivational and neuropeptidergic hub: anatomical and functional diversity within the Nucleus Accumbens shell","volume":"102","author":"Castro","year":"2019","journal-title":"Neuron"},{"issue":"16","key":"10.1016\/j.bcp.2026.118013_b0390","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.3390\/molecules28166012","article-title":"Functional and bioactive properties of wheat protein fractions: impact of digestive enzymes on antioxidant, \u03b1-amylase, and angiotensin-converting enzyme inhibition potential","volume":"28","author":"Gammoh","year":"2023","journal-title":"Molecules."},{"issue":"3","key":"10.1016\/j.bcp.2026.118013_b0395","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/jm00177a016","article-title":"Synthesis, in vitro opiate activity, and intramolecular tyrosine-tryptophan distances of (4-tryptophan) enkephalin analogs. a reassessment of conformational models of enkephalin in solution","volume":"23","author":"Schiller","year":"1980","journal-title":"J. Med. Chem."}],"updated-by":[{"DOI":"10.1016\/j.bcp.2026.118071","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:34:48Z","timestamp":1792888488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":79,"alternative-id":["S0006295226003461"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118013","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and neurobehavioral evaluation of the bifunctional opioid peptide Gluten exorphin B5","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118013"}}